The first mechanism is supported by the report that anti-TNFα treatment ameliorates insulin sensitivity [83] and also by the findings that TNFα-activated JNK directly phosphorylates IRS1/2, causing insulin resistance [80,84]. This evidence concerns the gene IRS1 and Insulin resistance.